Literature DB >> 25289412

T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone.

Suzanne M Vercauteren1, Daniel T Starczynowski, Sandy Sung, Kelly McNeil, Chris Salski, Clara-Lynn Jensen, Helene Bruyere, Wan L Lam, Aly Karsan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 25289412      PMCID： PMC4191868          DOI： 10.1111/j.1365-2141.2011.08872.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Integrating copy number polymorphisms into array CGH analysis using a robust HMM.

Authors:  Sohrab P Shah; Xiang Xuan; Ron J DeLeeuw; Mehrnoush Khojasteh; Wan L Lam; Raymond Ng; Kevin P Murphy
Journal:  Bioinformatics       Date:  2006-07-15       Impact factor: 6.937

2.  Resolving the resolution of array CGH.

Authors:  Bradley P Coe; Bauke Ylstra; Beatriz Carvalho; Gerrit A Meijer; Calum Macaulay; Wan L Lam
Journal:  Genomics       Date:  2007-02-02       Impact factor: 5.736

Review 3.  Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology.

Authors:  Patricia Disperati; Christine V Ichim; Douglas Tkachuk; Kathy Chun; Andre C Schuh; Richard A Wells
Journal:  Leuk Res       Date:  2005-07-25       Impact factor: 3.156

4.  Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting.

Authors:  I Miura; Y Kobayashi; N Takahashi; K Saitoh; A B Miura
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

5.  Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome.

Authors:  P K Epling-Burnette; J S Painter; D E Rollison; E Ku; D Vendron; R Widen; D Boulware; J X Zou; F Bai; A F List
Journal:  Leukemia       Date:  2007-02-15       Impact factor: 11.528

6.  Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.

Authors:  Alexander E Smith; Azim M Mohamedali; Austin Kulasekararaj; ZiYi Lim; Joop Gäken; Nicholas C Lea; Bartlomiej Przychodzen; Syed A Mian; Erick E Nasser; Claire Shooter; Nigel B Westwood; Corinna Strupp; Norbert Gattermann; Jaroslaw P Maciejewski; Ulrich Germing; Ghulam J Mufti
Journal:  Blood       Date:  2010-08-06       Impact factor: 22.113

7.  Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage.

Authors:  K van Lom; A Hagemeijer; E Smit; K Hählen; K Groeneveld; B Löwenberg
Journal:  Leukemia       Date:  1995-11       Impact factor: 11.528

8.  High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival.

Authors:  Daniel T Starczynowski; Suzanne Vercauteren; Adele Telenius; Sandy Sung; Kaoru Tohyama; Angela Brooks-Wilson; John J Spinelli; Connie J Eaves; Allen C Eaves; Douglas E Horsman; Wan L Lam; Aly Karsan
Journal:  Blood       Date:  2008-07-28       Impact factor: 22.113

Review 9.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

10.  Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes.

Authors:  L Ma; M Delforge; V van Duppen; G Verhoef; B Emanuel; M Boogaerts; A Hagemeijer; P Vandenberghe
Journal:  Leukemia       Date:  2004-09       Impact factor: 11.528
  10 in total
  4 in total

Review 1.  The bone-marrow niche in MDS and MGUS: implications for AML and MM.

Authors:  Irene M Ghobrial; Alexandre Detappe; Kenneth C Anderson; David P Steensma
Journal:  Nat Rev Clin Oncol       Date:  2018-01-09       Impact factor: 66.675

Review 2.  Cancer immune therapy for myeloid malignancies: present and future.

Authors:  Morten Orebo Holmström; Hans Carl Hasselbalch
Journal:  Semin Immunopathol       Date:  2018-07-09       Impact factor: 9.623

Review 3.  Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy.

Authors:  Francesca Garofano; Maria A Gonzalez-Carmona; Dirk Skowasch; Roland Schmidt-Wolf; Alina Abramian; Stefan Hauser; Christian P Strassburg; Ingo G H Schmidt-Wolf
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

Review 4.  Immune Mechanisms in Myelodysplastic Syndrome.

Authors:  Andreas Glenthøj; Andreas Due Ørskov; Jakob Werner Hansen; Sine Reker Hadrup; Casey O'Connell; Kirsten Grønbæk
Journal:  Int J Mol Sci       Date:  2016-06-15       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.